We describe a case of a mature cystic teratoma of the ovary with high proportion of solid thyroid tissue (< 50% of the entire tumor) in a childbearing woman. The patient presented with non-specific abdominal bloating. Pelvic ultrasound and magnetic resonance imaging revealed a complex cystic-solid tumor confined to the left ovary with an anterior fatcontaining locus compatible with mature cystic teratoma and a posterior predominantly solid component with low signal intensity on T2-weighted images that was histopatologically diagnosed as benign thyroid tissue. Thyroglobulin levels were in normal range. Although thyroid tissue is present in up to 20% of mature cystic teratomas, with exception of struma ovarii, it is not usually macroscopically nor radiologically identified. The differential diagnosis should include T2-hypointense adnexal lesions associated with mature cystic teratoma, malignant transformation of mature teratoma, and immature teratoma.
Although suggestive of mature cystic teratoma (MCT), the lesion was considered indeterminate on US, so magnetic resonance imaging (MRI) was performed.
MRI confirmed a complex cystic-solid tumor confined to the left ovary. The tumor was well defined and had two different components: an anterior demonstrated high signal intensity on T2-weighted (T2W) images (Figs. 2A and 2B) and high signal intensity on T1-weighted (T1W) images (Fig. 2C) , with signal drop on fat-suppressed T1W (FST1W) images (Fig. 2D) ; and a posterior component that was predominantly solid and demonstrated low signal intensity on T2W images (Figs. 2A and 2B) and low signal intensity on T1W images (Fig. 2C) . On diffusion-weighted images (DWI), the tumor (solid and fatty components) showed low signal intensity at a b value of 1000 sec/mm 2 ( Fig. 3A) , with correspondent low signal intensity on the apparent diffusion coefficient (ADC) map (Fig. 3B) . After gadolinium administration, the solid component showed moderate enhancement (Fig. 3C ), with a peak followed by a plateau (type 2 time-intensity curve (TIC)), on dynamic contrast-enhanced gadolinium (DCE) study (Fig.  3D ). This posterior solid component had a peripheral cystic locus that presented intermediate signal intensity on T1W images ( Fig. 2C ) with signal drop on T2W images -"shading" sign -( Fig. 2A) , and no enhancement after gadolinium administration (Fig. 3C) . A small amount of physiological fluid was detected in the rectouterine pouch ( Fig. 2A) . No metastases, nor lymphadenopathy or peritoneal implants were detected.
Management and follow up
Considering the aforementioned lesion demonstrated no features of malignancy and was considered resectable, only left salpingo-oophorectomy was performed. The pelvic and abdominal cavities were explored during surgery, and neither peritoneal implants nor lymphadenopathy were found.
The left ovary measured about 65mm x 65mm x 50mm and weighted 41 g; the capsule was intact and the ovary was almost completely replaced by a complex cystic-solid tumor. Macroscopically, the cystic component represented about 70% of the entire tumor and had irregular walls and viscous content with hair and sebum. The solid component represented the remaining 30% of the tumor and was brown and bright resembling thyroid tissue. Microscopically, the cystic component was lined by squamous epithelium with adnexal structures (Fig. 4A) . The solid component was composed of numerous small follicles filled with colloid. The ectodermal derivates from the cystic wall were clearly separated from thyroid tissue (Fig. 4B) .
The left fallopian tube was unremarkable.
Peritoneal fluid cytology was negative for neoplastic cells. The diagnosis of MCT with high proportion of thyroid tissue (< 50%) was made.
No further treatment was performed and the thyroglobulin levels were in normal range. To date the patient has undergone 3 years of follow-up without complications. We report a rare case of MCT with high proportion of thyroid tissue that was macroscopically identified but represented less than 50% of the entire tumor. Furthermore, this mature thyroid tissue showed a predominantly solid appearance as opposed to the multilocular cystic appearance with some solid components and variable signal intensity within cysts (owing to viscous colloid material) that macroscopically recognized thyroid tissue in ovary usually presents 1,2.
Complex mature cystic teratoma -differential diagnoses.
Mature teratomas are the most common ovarian neoplasm in women with less than 45 years old and are usually well characterized on US, computed tomography (CT), and MRI 3. However, according to their variable composition and possible complications (from rupture, torsion or malignancy), MCTs may have a variety of unusual clinical and imaging manifestations, thereby leading to misdiagnosis 3,4. Furthermore, in rare cases MCTs show atypical imaging findings because they do not contain fat or it is present as a combination or as a collision tumor. A combination tumor identifies a tumor in which intermixed varying histological components result from a common stem cell (e.g., mixed germ cell tumors), and a collision tumor identifies a tumor with two adjacent but histologically distinct tumors without histological admixture at the interface 3,5.
In our case, we described a complex cystic-solid tumor of the left ovary with an anterior fatty component compatible with a mature cystic teratoma on US and MRI associated with a prominent and indeterminate posterior solid mass. At MRI, there was a well-defined interface between the fatty component and the solid component, the capsule was intact and there were no signs of torsion or extra-ovarian malignancy. The posterior solid component showed low signal intensity on T2W (comparable to skeletal muscle) and on T1W images, which was suspicious for a stromal ovarian tumor. The moderate enhancement after contrast administration was suggestive of a Brenner tumor because fibroma and thecoma are usually hypovascular with weak enhancement 6,7. Therefore, the diagnosis of a collision tumor with mature cystic teratoma and Brenner tumor was considered. Although Brenner tumors can be associated with mucinous cystadenomas or other epithelial tumors in up to 20% of cases, the association with germ cell tumors is very rare 6,8.
Additionally, a prominent soft tissue component in a cystic teratoma, detected by any imaging modality should raise suspicion of a malignancy once the gross appearance of MCTs with malignant transformation is similar to the benign MCTs but with a more solid component 3,4. Approximately 1-2% of mature teratomas may undergo malignant degeneration in one of its elements. Squamous cell carcinoma is the most common subtype, occurring more frequently than basal cell carcinoma, melanoma, adenocarcinoma, sarcoma, neuroectodermal tumor, and thyroid cancer 9-11. However, malignant transformation in MCTs usually occurs in the 6 th or 7 th decade of life and the solid component usually tends to extend transmurally with direct invasion of neighboring pelvic DISCUSSION organs 4. In this case the tumor was confined to the left ovary, and no other signs of malignancy were present. Moreover, the solid component had low signal intensity on T2W images and low signal intensity on DWI obtained with a b value of 1000 sec/mm 2 , an important aspect that predicts benignity 12-14. Only a small amount of physiological fluid was detected in the rectouterine pouch and there were no peritoneal implants or lymphadenopathy. Therefore, malignant transformation was considered unlikely.
Another tumor that could be included in the differential diagnosis is immature teratoma (IT) because ITs may have a prominent solid component (usually with scattered calcifications) and cystic areas filled with serous or mucinous fluid, or even with fatty sebaceous material. However, ITs usually demonstrate malignant behavior, they are much less common than MCTs (representing only about 1% of ovarian teratomas), they mainly affect a younger age group (usually during the first 2 decades of life), and they are histologically distinguished by the presence of immature and/or embryonic tissues. ITs are also typically larger (14-25 cm) than mature teratomas at initial presentation, and typically demonstrate rupture of the capsule 3,4. According to these characteristics, IT was also considered unlikely.
Finally, the presence of small cysts with T2 "shading" sign (T2 shortening in an adnexal cyst that is hyperintense on T1W images) within a solid component that showed strong enhancement after contrast administration could raise the suspicion of the presence of thyroid tissue 6,15. However, in our case, the solid component only had one recognizable small cystic space, and the "shading" sign may also be found in several benign and malignant adnexal tumors, more frequently in endometriomas or endometrioid tumors 15.
Etiology & Demographics:
MCTs are the most common germ cell neoplasms in the ovary accounting for 20% to 30% of all ovarian tumors. MCTs are more likely to occur in the second and third decades of life (as in our case), and occur bilaterally in 10-15% of cases 4,16. MCTs are cystic tumors composed of welldifferentiated derivations from at least two of the three germ cell layers (ectoderm, mesoderm, and endoderm). While ectodermal tissue is invariably present and mesodermal tissue is present in the majority of cases, endodermal tissue is much less common 3,4.
Thyroid tissue originates from cells of endodermal tissue and can be identified histologically in up to 20% cases of MCTs. However, it is macroscopically recognized in less than 3% of MCTs, mainly corresponding to the variant form of teratoma denominated as struma ovarii (SO) 1,11. SO is the most common form of monodermal teratomas and is defined as an ovarian mature teratoma that is composed exclusively or predominantly of thyroid tissue (representing more than 50% of the entire tumor) 4. SO is characterized by the presence of macroscopically and histologically detectable thyroid tissue containing variable-sized follicles with colloid material separated by a prominent edematous to less often fibromatous stroma 3,4. Also included in this category, are cases of MCT having less than 50% of thyroid tissue but contain functional or histologically malignant thyroid tissue 17. SO has a peak incidence in the 5 th decade of life and accounts for 0.30%-0.65% of ovarian tumors and 2% of ovarian teratomas 1,6.
Reviewing the literature, there is no clear definition when benign thyroid tissue is macroscopically recognizable in MCTs but constitutes less than 50% of the ovarian tumor and has no functional nor malignant behavior. While some authors consider it as a MCT with high proportion of thyroid tissue, others consider it as a SO associated with a MCT. Interpreting the 4 th Edition of World Health Organization of Tumors of Female Reproductive Organs, we decided to consider this case as a mature cystic teratoma with high proportion of thyroid tissue (representing less than 50% of the entire tumor) 8.
Clinical & Imaging findings:
Most MCTs are asymptomatic and they are often discovered incidentally at routine pelvic examination. Abdominal pain or other non-specific symptoms may be present in a minority of patients. The diagnosis of simple MCTs is generally easily made through imaging. On US, MCTs usually vary from a classic cystic lesion with a densely echogenic tubercle (that represents the Rokitansky nodule) projecting into the cystic lumen, to a diffusely or partially echogenic mass with the echogenic area usually producing sound attenuation owing to sebaceous material and hair within the cystic cavity, up to multiple thin, echogenic bands caused by hair in the cystic cavity. On CT, fat attenuation within a cyst, with or without calcification in the wall, is diagnostic for MCT, whereas at MRI, the sebaceous component is specifically identified with fat-suppressed techniques 3,4. The components of benign teratomas display variable enhancement patterns after intravenous contrast administration and may rarely show malignant type 3 TIC on DCE-MRI 18.
Because it is rarely macroscopically or radiological identified, the presence of thyroid tissue in the ovary is essentially described when it is the predominant component as in cases of SO 1-3. As well as patients with MCTs, most patients with SO are asymptomatic or present with nonspecific symptoms 1. Clinical evidence of hyperthyroidism occurs in about 5% of cases of SO 6,19. Imaging findings are usually non-specific. On US, SO usually presents as a multilocular cystic ovarian mass with solid components of various amounts 1. CT demonstrates the complex appearance of the tumor with multiple cystic and solid areas, with foci of high attenuation on non-contrast images 2. At MRI, the cystic spaces usually demonstrate variable appearance, with some cysts presenting low signal intensity on both T1W and T2W images, and other cysts presenting low signal intensity on T2W images and intermediate signal intensity on T1W images due to thick, highly viscous, and gelatinous colloid material. There are also cysts with high signal intensity on T1W images owing to hemorrhage 1,2,20,21. The solid components, corresponding microscopically to thyroid tissue with microfollicular appearance, are of low signal intensity on T2W images and intermediate signal intensity on T1W images and should be considered on the differential diagnosis of T2-hypointense lesions 1,6. Following administration of intravenous contrast material, the solid components usually exhibit strong enhancement on enhanced FST1W images and enhance at the early phase of DCE-MRI 1,18. SO are benign in 95% of cases and usually occur in premenopausal women. The rare cases of malignant SO are usually papillary thyroid cancer and the diagnosis is based on histological features of the resected ovary, as no specific imaging features are available to detect malignant struma, despite the same criteria applied to detect malignancy in teratomas could be considered 1,11.
Treatment & Prognosis:
Once diagnosed, MCTs have routinely been removed by elective surgery. However, expectant management is feasible in asymptomatic women because the risk of cysts becoming symptomatic is low. Intervention should be considered in younger multiparous women, particularly if the cysts are large and bilateral 22. MCTs of the ovaries may be removed by simple ovarian cystectomy rather than salpingo-oophorectomy. Although malignant degeneration is quite rare, the cyst should be removed in its entirety and if immature elements are found, the patient should undergo a standard staging procedure 23,24. Laparoscopic management of MCTs is a safe and efficient procedure, offering a shorter hospital stay, a quicker recovery, and allows a conservative treatment, very important in premenopausal women who want to preserve their fertility 25. In the last decade, single port laparoscopic surgery has been introduced as a further development of laparoscopy, and recently single port robotic surgery has been successfully performed in ovary cystectomy, with potential advantages on the superiority of magnified 3-dimensional view, more precise dissection, and improved homeostasis 26.
According to the few reports available, the rate of postsurgical recurrence of MCT is usually 3-4%. Younger age (< 30 years), large cyst size (diameter > 80 mm), and bilaterality, are predictive risk factors for recurrence, with the risk of recurrence being especially high in the presence of more than one of these factors 27,28.
Although the diagnosis of mature cystic teratomas is in general easily made through imaging, according to their different composition and possible complications they may have a variety of unusual clinical and imaging manifestations, thereby leading to misdiagnosis. At MRI, mature thyroid tissue in the ovary may have a predominantly solid appearance with low signal intensity on T2-weighted images resembling stromal tumors and should be included in the differential diagnoses of T2-hypointense adnexal lesions, particularly when associated with fatty components. 
REFERENCES TEACHING POINT

Etiology
Germ cell tumor of the ovary Incidence Mature cystic teratoma accounts for 10-20% of all ovarian neoplasms Thyroid tissue is present in up to 20% of cases of MCTs but is macroscopically recognized in less than 3%. Gender ratio Women Age predilection < 45 years old
Risk factors Unknown Treatment
Ovarian cystectomy / Salpingo-oophorectomy Prognosis Two major complications: torsion (mean diameter 11 cm) and malignant transformation (risk 1-2%)
Findings on imaging
Ultrasound:
MCT: cystic lesion with a densely echogenic tubercle (that represents the Rokitansky nodule); thin band-like echoes; fat-fluid level. Thyroid tissue in ovary: hyperechoic mass often vascularized on Doppler flow, with areas of cystic degeneration.
Computed Tomography:
MCT: fat within the tumor (typically measuring -20 HU or lesser); fat-fluid levels; sometimes a raised protuberance (Rokitansky nodule) is visible and may have bone or teeth. Thyroid tissue in ovary: complex appearance with cystic and solid areas, and foci of high attenuation on noncontrast images.
Magnetic Resonance Imaging:
MCT: hyperintense on T1W images, with signal drop on FST1W images; intermediately intense to hyperintense on T2W images; variable signal on DWI (epidermoid components may have high signal on high b values and a low ADC value). Thyroid tissue in ovary: multiloculated cystic mass with solid components of various amounts; cystic areas might have variable signal on T1W and T2W images due to colloid and/or hemorrhage; solid components with low signal intensity on T2W images and intermediate signal intensity on T1W images. 
